Better Mab Trademark Details
Word Mark | Better Mab |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Serial Number | 85482864 |
---|---|
Status Date | Monday, February 1, 2016 |
Filing Date | Monday, February 1, 2016 |
Attorney | David L. May |
Correspondent
DAVID L. MAY
NIXON PEABODY, LLP
401 9TH ST N.W. STE 900
WASHINGTON, DC 20004
NIXON PEABODY, LLP
401 9TH ST N.W. STE 900
WASHINGTON, DC 20004
Case File Statements
Indication of Colors | Color is not claimed as a feature of the mark. |
---|---|
Disclaimer with Predetermined Text | "Mab" |
Goods & Services | Chemicals, biochemicals and reagents for use in industry and science; Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting cellular activity or gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in modifying and regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; antibodies for scientific and research use; antibodies for regulating, modifying or regulating cellular functions in plants, fungi and animals, and in cells of plants, fungi and animals; kits consisting primarily of proteins for regulating, modifying or restricting cellular activity or gene expression; Research reagents for pharmaceutical discovery or disease research, drug discovery or drug development; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for industrial and agricultural applications; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof |
Goods & Services | Chemical preparations for medical and veterinary purposes, namely, chemical preparations for regulating, modifying, or restricting cellular activity or gene expression for purposes of treating diseases and genetic disorders; chemical preparations for antibody therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for therapeutic analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for antibody therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for antibody therapy analysis; Pharmaceutical preparations for modifying or regulating one or more cellular functions of mammals, fungi, plants, and bacteria and transgenic mammals, fungi, plants, and bacteria; transgenic plants, fungi and bacteria for medical and veterinary purposes; antibodies for use in disease testing; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof |
Goods & Services | Custom manufacturing and custom synthesis of antibodies and genetically engineered DNA expressing antibodies, biological organisms, cells, viruses, pathogens and special purpose cells to the specifications of others for scientific, research, medical, veterinary and laboratory use; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof |
Goods & Services | Development of new technology for others in the field of genetics, therapeutics and biotechnology; Development of products being antibodies and genetic therapies expressing antibodies to regulate, modulate, treat, prevent, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the fields of biotechnology and antibody technology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells expressing antibodies for scientific, research, medical, veterinary and laboratory use; Scientific research and product development services for others in the pharmaceutical, biotechnology, biosensors, bioelectronics, medical and agriculture fields; Antibody technology and gene therapy services for others for product development and scientific research purposes, namely, antibody production, genetically engineering DNA expressing antibodies, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical, veterinary and laboratory use; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof |
Goods & Services | Medical services; Medical services, namely, antibody and gene therapy services; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof |
Goods & Services | Technology transfer services, namely, licensing and transfer of intellectual property; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof |
Classifications
International Class Codes |
001
|
---|---|
U.S. Class Codes | 001, 005, 006, 010, 026, 046 |
Status | 6 — Active |
Status Date | Monday, December 5, 2011 |
Primary Code | 001 |
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Monday, December 5, 2011 |
Primary Code | 005 |
International Class Codes |
040
|
---|---|
U.S. Class Codes | 100, 103, 106 |
Status | 6 — Active |
Status Date | Monday, December 5, 2011 |
Primary Code | 040 |
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Monday, December 5, 2011 |
Primary Code | 042 |
International Class Codes |
044
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Monday, December 5, 2011 |
Primary Code | 044 |
International Class Codes |
045
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Monday, December 5, 2011 |
Primary Code | 045 |
Trademark Timeline
-
Nov 29 2011Trademark application filed with USPTO
-
Dec 02 2011New Application Entered In Tram
-
Dec 05 2011New Application Office Supplied Data Entered In Tram
-
Mar 12 2012Assigned To Examiner
-
Mar 14 2012Notification of Non-Final Action E-Mailed
-
Mar 14 2012Non-Final Action E-Mailed
-
Mar 14 2012Non-Final Action Written
-
Jul 19 2012Correspondence Received In Law Office
-
Jul 19 2012Teas Response To Office Action Received
-
Jul 20 2012Teas/email Correspondence Entered
-
Jul 27 2012Approved For Pub - Principal Register
-
Jul 27 2012Examiner's Amendment Entered
-
Jul 27 2012Notification of Examiners Amendment E-Mailed
-
Jul 27 2012Examiners Amendment E-Mailed
-
Jul 27 2012Examiners Amendment -Written
-
Aug 10 2012Law Office Publication Review Completed
-
Aug 10 2012Assigned To Lie
-
Aug 26 2012Withdrawn From Pub - Og Review Query
-
Sep 04 2012Previous Allowance Count Withdrawn
-
Sep 07 2012Notification of Non-Final Action E-Mailed
-
Sep 07 2012Non-Final Action E-Mailed
-
Sep 07 2012Non-Final Action Written
-
Sep 20 2012Approved For Pub - Principal Register
-
Sep 20 2012Examiner's Amendment Entered
-
Sep 20 2012Notification of Examiners Amendment E-Mailed
-
Sep 20 2012Examiners Amendment E-Mailed
-
Sep 20 2012Examiners Amendment -Written
-
Sep 21 2012Law Office Publication Review Completed
-
Oct 10 2012Notification of Notice of Publication E-Mailed
-
Oct 30 2012Official Gazette Publication Confirmation E-Mailed
-
Oct 30 2012Published For Opposition
-
Dec 25 2012Noa E-Mailed - Sou Required From Applicant
-
Jun 18 2013Extension 1 Granted
-
Jun 18 2013Extension 1 Filed
-
Jun 18 2013Teas Extension Received
-
Jun 20 2013Notice of Approval of Extension Request E-Mailed
-
Dec 04 2013Extension 2 Filed
-
Dec 04 2013Teas Extension Received
-
Jan 24 2014Case Assigned To Intent To Use Paralegal
-
Jan 24 2014Case Assigned To Intent To Use Paralegal
-
Jan 30 2014Extension 2 Granted
-
Jan 31 2014Notice of Approval of Extension Request E-Mailed
-
May 28 2014Extension 3 Filed
-
May 28 2014Teas Extension Received
-
Jun 02 2014Extension 3 Granted
-
Jun 03 2014Notice of Approval of Extension Request E-Mailed
-
Dec 11 2014Extension 4 Filed
-
Dec 11 2014Teas Extension Received
-
Dec 15 2014Extension 4 Granted
-
Dec 16 2014Notice of Approval of Extension Request E-Mailed
-
Jun 23 2015Extension 5 Filed
-
Jun 23 2015Teas Extension Received
-
Jul 08 2015Extension 5 Granted
-
Jul 09 2015Notice of Approval of Extension Request E-Mailed
-
Feb 01 2016Abandonment Notice Mailed - No Use Statement Filed
-
Feb 01 2016Abandonment - No Use Statement Filed